Despite its potential, AhR signaling is often dysregulated in AD, with increased expression and reduced pathway activation, as shown by the decreased expression of target genes such as CYP1A1 in lesional skin [4,8]. The gene discussed is CYP1A1; the disease is Alzheimer disease.